Abstract:Uterine fibroids are the most common mesenchymal uterine neoplasms; their prevalence is estimated in 40%–60% of women under 35 and in 70%–80% of women over 50 years of age. The current research aims to focus on the etiopathogenesis of uterine fibroids, the factors that affect their growth, and markers with diagnostic and prognostic properties. The MCM (minichromosome maintenance) protein family consists of peptides whose primary function is participation in the molecular mechanism of creating replication forks while regulating DNA synthesis. The aim of this work was to determine the proliferative potential of uterine fibroid cells based on the expression of the Ki-67 antigen and the MCMs—i.e., MCM-3, MCM-5, and MCM-7. In addition, the expression of estrogen (ER) and progesterone (PgR) receptors was evaluated and correlated with the expression of the abovementioned observations. Ultimately, received results were analyzed in terms of clinical and pathological data. Materials and methods: In forty-four cases of uterine fibroids, immunohistochemical reactions were performed. A tissue microarray (TMA) technique was utilized and analyzed cases were assessed in triplicate. Immunohistochemistry was performed using antibodies against Ki-67 antigen, ER, PgR, MCM-3, MCM-5, and MCM-8 on an automated staining platform. Reactions were digitalized by a histologic scanner and quantified utilizing dedicated software for nuclear analysis. Assessment was based on quantification expression of the three histiospots, each representing one case in TMA. Results: In the study group (uterine fibroids), statistically significant stronger expression of all the investigated MCMs was observed, as compared to the control group. In addition, moderate and strong positive correlations were found between all tested proliferative markers. The expression of the MCM-7 protein also correlated positively with ER and PgR. With regard to clinical and pathological data, there was a negative correlation between the expression of MCMs and the number of both pregnancies and births. Significant reductions in MCM-5 and MCM-7 expression were observed in the group of women receiving oral hormonal contraceptives, while smoking women showed an increase in MCM-7, ER, and PgR. Conclusions: Uterine fibroid cells have greater proliferative potential, as evaluated by expression of the Ki-67 antigen and MCMs, than unaltered myometrial cells of the uterine corpus. The expression of MCM-7 was found to have strong or moderate correlations in all assessed relations. In the context of the clinical data, as well evident proliferative potential of MCMs, further studies are strongly recommended.

C-Mos Immunoreactivity Aids in the Diagnosis of Gestational Trophoblastic Lesions

Discovery and Validation of Novel Biomarkers for Detection of Cervical Cancer

Analysis of PD-L1 Expression in Trophoblastic Tissues and Tumors.

Challenges in Diagnosing Hydatidiform Moles: a Review of Promising Molecular Biomarkers.

Minichromosome maintenance protein 7 expression in gestational trophoblastic disease: correlation with Ki67, PCNA and clinicopathological parameters.

Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia: PSCA and trophoblastic neoplasia

Expression of KCNQ1 and P57kip2 and Their Clinical Significance in Hydatidiform Mole

Using Short Tandem Repeat Analysis for Choriocarcinoma Diagnosis: a Case Series

[Mismatch Repair Gene Promoter Methylation and Expression in Hydatidiform Moles and the Malignant Transformation].

[Expression and Significance of LMP2 and PPM1A in Gestational Trophoblastic Disease].

[Clinicopathological Study of Intermediate Trophoblastic Non-Tumor Lesions: Exaggerated Placental Site and Placental Site Nodule].

Expression of immunohistochemical markers according to histological type in patients with early gastric cancer

Telomerase RNA and Telomerase Activity in Trophoblastic Tumors

P21waf1/cip1 Expression in Gestational Trophoblastic Disease: Correlation with Clinicopathological Parameters, and Ki67 and P53 Gene Expression.

Immunohistochemical and Mutational Analysis of P53 Tumor Suppressor Gene in Gestational Trophoblastic Disease: Correlation with Mdm2, Proliferation Index, and Clinicopathologic Parameters

p21(WAF1/CIP1) expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression

C-myc Expression in Early Human Placenta--a Critical Evaluation of Its Localization.

Differential expression of insulin-like growth factor binding protein 1 and ferritin light polypeptide in gestational trophoblastic neoplasia: combined cDNA suppression subtractive hybridization and microarray study.

The Immunohistochemical Expression of MCM-3, -5, and -7 Proteins in the Uterine Fibroids

p21 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression

Methylation Status and Expression of E-cadherin and Cadherin-11 in Gestational Trophoblastic Diseases